Penserra Capital Management LLC Ac Immune Sa Transaction History

Penserra Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$4.83 - $7.56 $8,790 - $13,759	-1,820 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$6.2 - $8.34 $1,023 - $1,376	165 Added 9.97%	1,820 $12,000
Q2 2021 Aug 12, 2021	BUY	$6.04 - $8.37 $181 - $251	30 Added 1.85%	1,655 $13,000
Q1 2021 May 13, 2021	SELL	$5.32 - $8.96 $106 - $179	-20 Reduced 1.22%	1,625 $12,000
Q4 2020 Feb 12, 2021	BUY	$4.47 - $5.58 $4,635 - $5,786	1,037 Added 170.56%	1,645 $8,000
Q3 2020 Nov 13, 2020	BUY	$4.78 - $9.06 $2,906 - $5,508	608 New	608 $2,000

28.2M

150K

12.4K

Ticker ACIU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,413,504
Market Cap $296M
Description
AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. Its SupraAntigen and Morphomer platforms are designed to generate vaccines, antibodies, and small molecules, which selectiv...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.